Consolidated Financial Results for the 2nd Quarter of the Fiscal Year Ending March 31, 2018

from the beginning

Consolidated Financial Results for the 2nd Quarter of the Fiscal Year Ending March 31, 2018

Disclaimer

Voluntary Adoption of IFRS

Highlights

Consolidated Financial Results and Business Overview for the 2Q of Fiscal 2018(FY Ending March 31, 2018)

2Q of Fiscal 2018 (1) Consolidated Financial Results

2Q of Fiscal 2018 (1) Factors Influences Consolidated Operating Profit

2Q of Fiscal 2018 (2) Results by Business Segment

2Q of Fiscal 2018 (2) Medical Business

2Q of Fiscal 2018 (3) Medical Business

2Q of Fiscal 2018 (4) Scientific Solutions Business

2Q of Fiscal 2018 (5) Imaging Business

Statement of Financial Position

Consolidated Cash Flows

Investments (R&D Expenditures, Capital Expenditures, Depreciation and Amortization)

Forecast for Fiscal 2018

Forecasts of Consolidated Financial Results for Fiscal 2018 (Full-year basis)

Segment Forecasts for Fiscal 2018 (Full-year basis)

2nd-half Forecast for Fiscal 2018 by Segment (YoY)

@

Appendix

【Supplementary Materials (JGAAP/IFRS) 】 FY2017 1H Results (1) Consolidated

【Supplementary Materials (JGAAP/IFRS) 】 FY2017 1H Results (2) Factors Influencing OP

【Supplementary Materials (JGAAP/IFRS) 】 FY2017 1H Results (3) Factors Influencing Profit

【Supplementary Materials (JGAAP/IFRS) 】 FY2017 1H Results (4) By segment

【Supplementary Materials (JGAAP/IFRS) 】 FY2017 Full Year Results (1) Consolidated

【Supplementary Materials (JGAAP/IFRS) 】 FY2017 Full Year Results (2) Factors Influencing Operating Profit

【Supplementary Materials (JGAAP/IFRS) 】 FY2017 Full Year Results (3) Factors Influencing Profit

【Supplementary Materials (JGAAP/IFRS) 】 FY2017 Full Year Results (4) By segment

Q&A

• Q&A 1

• Q&A 2

• Q&A 3

• Q&A 4

• Q&A 5

• Q&A 6